One significant trend in the market is the rise in endovascular treatments for DAVF. Minimally invasive endovascular embolization techniques involving catheter implantation into blocking blood vessels have emerged as a leading modality among practitioners referring patients for surgical excision. In response to such a development, less invasive approaches are becoming more popular as they paving way from open surgeries hence improving prognosis.
Another trend is the growing market focus on multidisciplinary care. In case of DAVF, specialists and neurosurgeons work together with other nurses in order to provide patients with treatment services that are comprehensive as well as individualized. Both aspects of this condition – vascular and neurological – should be taken into account by a multidisciplinary approach for management of its complex nature. This demonstrates the all-roundedness in patient care, improving outcomes through systemic approaches among myriad medical disciplines.
The treatment of DAVFs has also seen an increasing shift towards use of flow-diverting stents. The use of these devices can result in blood flow being re-directed such that aberrant vessels close naturally over time. Most importantly, this offers a potential alternative to traditional embolization techniques for complex and challenging DAVFs. As a result, more cases have been provided with different methods for treating this type of vascular disease.
Also significant is the growing understanding concerning the natural course of dural arteriovenous fistulas (DAVF) from ongoing research endeavors aimed at identifying progressive or complicated factors among them. Therefore, it is now possible to make informed treatment decisions based on these predictions which allow healthcare professionals to tailor interventions according to the specific characteristics associated with each case.
Moreover, there is a tendency towards utilization of new technologies in providing patient care. This makes it possible for such patients who live far away from specialized centers to have access to telemedicine or virtual consultations as they seek medical assistance thereby breaking geographical barriers between them and their doctors. Since DAVF is rare, this trend aims at overcoming issues related to geographic constraints hence ensuring that individuals affected by the condition get expert opinions about it.
The dural arteriovenous fistulas treatment market is expected to grow at a CAGR of 6.60% during the forecast period 2022-2030.Dural arteriovenous fistulas (DAVF) is caused by abnormal connections between arteries and veins in a protective membrane on the outer layer of the brain and spine; it is a rare disease. These abnormal blood vessels divert blood from the normal paths. If the volume of diverted blood flow is large, tissue downstream may not receive an adequate blood and oxygen supply. The symptoms vary, depending on the location of fistulae. Headaches are among the most common symptoms with all types of DAVFs. Other symptoms include visual problems, ringing in ears, heart strokes, and others.
Increasing prevalence of brain injury and neurological disorders, increasing investment in biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the dural arteriovenous fistulas treatment market. Moreover, favorable reimbursement policies, increased applications, and significant investments in the development of advance technologies for the treatment methods likely to fuel the dural arteriovenous fistulas treatment market growth during the forecast period 2017-2023.
As per the Centers for Disease Control and Prevention in 2014, about 2.8 million TBI-related Emergency Department (ED) visits, hospitalizations, and deaths occurred in the United States. TBI (traumatic brain injury) contributed to the deaths of nearly 50,000 people. It was diagnosed in over 282,000 hospitalized cases and over 2.5 million ED visits. These consisted of TBI alone or TBI in combination with other injuries. Adults aged over 75 years have the highest rates of TBI-related hospitalization and deaths.
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of gastrointestinal disorders, or cancers, and is expected to increase further over the coming years.
However, higher cost of these treatment procedure may hamper the dural arteriovenous fistulas treatment market growth during the corresponding period.
Intended Audience
Sources: Annual reports, Press release, White paper, Company presentation
Segmentations
The dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.
On the basis of type, the dural arteriovenous fistulas treatment market is segmented into type I, type II, and type III.
On the basis of application, the dural arteriovenous fistulas treatment market is segmented into surgery, stereotactic radiosurgery, embolization, and others.
On the basis of end user, the dural arteriovenous fistulas treatment market is segmented into hospitals & clinics, ambulatory surgical centers, and others.Â
Regional Analysis
The Americas dominates the dural arteriovenous fistulas treatment market owing to developing  technology, increasing cases of brain injury, rising prevalence of neurological disorders, growing healthcare spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the dural arteriovenous fistulas treatment market. It is expected that the government support for research & development and availability of funds for research may drive the market in European region over the review period.
Asia Pacific is the fastest growing dural arteriovenous fistulas treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries such as China, India, Japan, and South Korea projected to emerge as the fastest growing market across the globe. Furthermore, increasing demand for the neurological treatment may lead to the use of advanced equipment, which, in turn, will increase the growth of the dural arteriovenous fistulas treatment market in the region.
On the other hand, the Middle East and Africa holds the least share of the market due to limited medical facilities, lack of funds for research and development, and poor political conditions, especially, in Africa.
Key Players
Some of key the players in the dural arteriovenous fistulas treatment market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited.Â
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
Â
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)